The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending flexibilities for compounded products. The grace period for manufacturers ...

The FDA is giving makers of compounded semaglutide, the active ingredient ... don’t want to be competition and “are trying to alert patients to the fact that, if they’ve been taking a ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

The Outsourcing Facilities Association filed two lawsuits against the FDA about the removal of Tirzepatide and Semaglutide from the drug shortage list, but judges allowed the FDA’s plan to ban the ...

The FDA may begin enforcement actions against pharmacies compounding unauthorized semaglutide after May ... in-one trading dashboard with real-time alerts, rankings, and stock ideas—60% off ...

ASHLAND A weight loss clinic with multiple locations in Kentucky, including Ashland, is facing accusations of providing ...

Printed with permission The FDA began allowing the distribution of compounded semaglutide and tirzepatide ... as a concern for the FDA in an alert released in July. The FDA stated it received ...